Viewing nowSimvastatin Tablet 20mg (Simvastatin)
Simvastatin 20mg
Tablet · Prescription medication
Jeongwoo Pharmaceutical Co., Ltd.

MFDS item code 201604370 · Approved 2016.07.14
Improvement of hyperlipidemia (including familial hypercholesterolemia in children) and reduction of cardiovascular disease risk
This medication is used to reduce the risk of cardiovascular diseases. It decreases the risk of coronary events in adult patients with coronary heart disease, diabetes, peripheral vascular disease, and stroke. Additionally, in patients with hyperlipidemia, it helps to lower total cholesterol and LDL cholesterol levels while raising HDL cholesterol levels. It can be used in conjunction with diet for adults and pediatric patients with familial hypercholesterolemia, effectively managing LDL cholesterol levels. Overall, it is used to improve health through the prevention of cardiovascular diseases and the management of hyperlipidemia.
Before and during treatment with this medicine, patients must follow a standard cholesterol-lowering diet. 1. Reduction of the risk of cardiovascular disease Adult patients at high risk of coronary heart disease events because of a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is simvastatin 40 mg once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. A dose of 5 ~ 40 mg of this medicine once daily in the evening is recommended. Adjust the dose as appropriate according to the initial LDL cholesterol level before treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and regularly thereafter to adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, use of this medicine at a dose of 80 mg, particularly during the first year of treatment, should be limited to patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) See the information below for the recommended doses in patients receiving this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment) (see 6. Interactions under Precautions for Use). (1) Use in patients with homozygous familial hypercholesterolemia Based on controlled clinical trial results, patients with homozygous familial hypercholesterolemia should receive 40 mg of this medicine once daily in the evening. This medicine should be used in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not available. (2) In elderly patients, the maximum reduction in cholesterol levels may be achieved with a daily dose of 20 mg of this medicine. (3) Use in patients receiving verapamil, diltiazem, or dronedarone When this medicine is coadministered with verapamil, diltiazem, or dronedarone, the dose of this medicine should not exceed 10 mg per day. (4) Use in patients receiving amiodarone, amlodipine, or ranolazine When this medicine is coadministered with amiodarone, amlodipine, or ranolazine, the dose of this medicine should not exceed 20 mg per day. (5) Concomitant use with other lipid-lowering agents This medicine is effective when used alone or in combination with a bile acid sequestrant. When this medicine is coadministered with a fibrate (excluding gemfibrozil (see 2. Do not administer to the following patients under Precautions for Use) and fenofibrate), the dose of this medicine should not exceed 10 mg per day. (6) Use in patients with renal impairment Because this medicine is not extensively excreted by the kidneys, dose adjustment is not necessary in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, initiate treatment at 5 mg once daily and monitor carefully.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg once daily, and the recommended maximum dose is 40 mg per day. Adjust the dose appropriately for each patient according to the recommended treatment goal. Allow an interval of 4 weeks or longer between dose adjustments.
This medication may cause muscle abnormalities, so patients taking high doses should consult a doctor immediately if they experience muscle pain or weakness symptoms. It can affect liver function, thus it should not be taken by patients with liver disease or abnormal liver enzyme levels. Women who are pregnant or may become pregnant and nursing mothers should not take this medication. Serious side effects may occur when taken with certain medications, so patients should inform their doctor if they are taking other medications. Patients who consume excessive alcohol or have liver or kidney issues should take this medication with caution and regular monitoring is required. Elderly patients and women are at higher risk of developing myopathy, so caution is advised during administration. Symptoms may occur such as headache, dyspepsia, constipation, diarrhea, nausea; if symptoms are severe or persistent, consult a healthcare professional. This medication may elevate blood glucose levels, so patients at risk of diabetes should check their blood sugar regularly. Report any new symptoms or adverse reactions to healthcare professionals immediately during treatment. Store this medication out of reach of children and keep it in its original container. In case of overdose, standard emergency treatments should be received and immediate medical assistance is necessary.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to protect it from exposure to air or moisture. The appropriate storage temperature is room temperature between 1 to 30 degrees Celsius. Avoid storing in extremely hot or cold places.
Brownish-yellow oval film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSimvastatin 20mg
Tablet · Prescription medication
Jeongwoo Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Jongkundang Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Korea Hutech Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Yuhan Corporation

Simvastatin 40mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Dongsung Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.